Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 2 ... A new, first-of-its-kind diabetes algorithm created to help achieve glycemic (blood sugar) control in type 2 patients was ... Enzyme, Combination Therapy, Complications, Endocrine, Endocrinology, Genetics, Genomics, Non-insulin Dependent Diabetes Mellitus, Treatment, Type 2 Diabetes Mellitus, American ... a consensus statement from the American Association of Clinical Endocrinologists (AACE) and the American College of Endocrinology (ACE), is a simple one-page resource designed to ...
2009 NOV 2 ... health - including their predisposition for developing health conditions such as type 2 diabetes, cancer, heart attack, and celiac disease. Working with one of Navigenics' ... Beth Israel Deaconess Medical Center and Navigenics, Inc., a leading personal genomics company, announced a collaboration to make personalized genomics available to doctors in ... analyzed through Navigenics genetic testing services. "We believe that genetics and genomics will be critical to the future of health care," said Mark Boguski, M.D., ...
2009 NOV 16 ... Keywords: United States, Atlanta, Amyotrophic Lateral Sclerosis, Biotechnology, Diabetes, Diabetic Neuropathy, Drug Delivery, Endocrinology, Gene Therapy, Genetics, Genomics, ... "IN THIS REVIEW, we describe how therapies that promote axonal regeneration and neuronal protection can complement surgery for a successful functional restoration in ...
2009 NOV 2 ... disease, peripheral arterial disease, stroke, transient ischemic attack or high-risk diabetes with evidence of end-organ damage. Some studies estimate that up to 20 percent of ... Disease, Coronary Artery Disease, Diabetes, Drug Development, Drugs, FDA, Genetics, Genomics, Heart Attack, Heart Disease, Hypertension, Micardis, Myocardial Infarction, ... Boehringer Ingelheim Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for its ...
2009 NOV 2 ... year. Genzyme continues to explore expanded uses for Thymoglobulin, including in Type 1 diabetes, where it is conducting a phase 2 trial in conjunction with the Immune Tolerance ... FDA, Fabrazyme, Gaucher Disease, Genetic Diseases, Genetic Disorders, Genetics, Genomics, Genzyme Corporation, Gynecology, Hematology, Hepatology, Imiglucerase, Knee Pain, ... the temporary interruption in production of Cerezyme® (imiglucerase for injection) and Fabrazyme® (agalsidase beta) associated with the remediation of the company's ...
2009 NOV 16 ... and to identify strategies for predicting and preventing human diseases such as cancer, diabetesand AIDS. ISB's systems approach integrates biology, computation and technological ... The Institute for Systems Biology (ISB) and Complete Genomics Inc. announced that they are embarking on a large-scale human genome sequencing study of ... visit http://www.completegenomics.com. Keywords: , Health, Biotechnology, Genetics, Mental Health, General Health, Technology, Central Nervous System Disease, Genetics, ...
2009 NOV 9 ... life sciences for the 3D display of molecules implicated in diseases such as cancer anddiabetes. ActiveICM can also be used for any online publication where a 3D view would enhance the ... for scientific publishing because of a collaboration with scientists at the Structural Genomics Consortium in the UK. Initially the technology is being applied to the life sciences for ... MolSoft, Cancer, Oncology, Diabetes, Marketing and Licensing Agreements, Genomics, Genetics. This article was prepared by Biotech Business Week editors from staff and ...
2009 NOV 16 ... patients with CVD were significantly older compared to those without CVD (P = 0.02). Diabetes status was significantly associated with cardiovascular events (P = 0.01)," wrote S. ... Disease, Diabetes, Endocrinology, Enzymes, Gender Health, Gender Medicine, Genetics, Genomics, Genotyping, Heart Disease, Hemodialysis, Hyperhomocysteinemia, Nephrology, Reductase, ... "Cardiovascular disease (CVD) remains the main cause of morbidity and mortality in end stage renal disease (ESDR) patients. A common C-T mutation at ...
2009 NOV 16 ... cells, and toward our ultimate goal, finding cures for such diseases as ALS anddiabetes." "Stem cells have the greatest potential to dramatically change and ... Biotechnology, Cancer Gene Therapy, DNA, Diabetes, Embryonic Stem Cells, Genetics, Genomics, Oncology, Small Molecule Inhibitor, Stem Cell Research, Treatment, Virology. ...
2009 NOV 2 ... The result can be irreversible scarring of the liver (cirrhosis), liver cancer, diabetes, heart failure, heart rhythm problems, arthritis, impotence or darkening of the skin. ... Arthritis, Cardiology, Diabetes, Fatigue, Fibrosis, Genetic Disorders, Genetics, Genomics, Heart Disease, Heart Failure, Hemochromatosis, Hepatology, Immunology, Impotence, Iron ... Treatment for Common Genetic Disorder ROCHESTER, Minn. -- Absorbing and storing too much iron can cause an array of health problems -- for starters, joint pain, ...
2009 NOV 23 ... Biotechnology Company, COX-2 Inhibitors, Cancer, Chronic Pain, Clinical Trial Research, Diabetes, Diabetic Neuropathy, Diagnostics, Drug Development, Endocrinology, Genetics, Humanized ... was originally discovered by Professor Antonino Cattaneo in the laboratories of Lay Line Genomics, in Rome. About Abbott:Abbott is a global, broad-based health care company devoted to ... biologic. PG110 is currently in a Phase 1 clinical trial in patients with osteoarthritis and represents a promising new therapeutic for the treatment of chronic pain. The agreement ...
2009 NOV 23 ... progress in discovering genes linked to chronic health conditions such as cancer, diabetes, cardiovascular disease, and obesity," said Chief Scientific Officer for Pathway ... Pathway Genomics™ (www.PATHWAY.com), a privately held, venture-backed company, announced an ... Health Test will empower consumers to assess their health risks, looking at their genetics, family history, and lifestyle choices, and discuss with their physician treatment ...
2009 NOV 23 ... highly specific for pancreatic beta-cells and enable imaging and quantification in vivo. Diabetes 58:2324-2334, 2009." Ueberberg and colleagues published their study in ... City:Bochum, Country:Germany, Biotechnology, Diabetes, Gastroenterology, Genetics, Genomics, Imaging Agent, Medical Device, Pancreas, Phage Libraries, Proteomics, Ruhr University. ...
2009 NOV 2 ... Keywords: United States, Augusta, Acute Myeloid Leukemia, Biotechnology, Deacetylase, Diabetes, Enzyme Research, Gene Therapy, Genetics, Genomics, Hematology, Hydrolase, ... States, "The polycomb repressive complex (PRC) 2 contains 3 core proteins, EZH2, SUZ12, and EED, in which the SET (suppressor of variegation-enhancer of zeste-trithorax) domain of ...
2009 NOV 23 ... "Atherosclerosis is accelerated in subjects with type 2 diabetes by unknown mechanisms. We identified tissue inhibitor of metalloproteinase 3 (TIMP3), ... Atherosclerosis, Biotechnology, Cardiology, Diabetes, Enzymes, Gene Therapy, Genetics, Genomics, Inflammation, Insulin, Insulin Resistance, Matrix Metalloproteinase, Metalloprotease, ... inhibitor of metalloproteinase 3 (TIMP3), the endogenous inhibitor of A disintegrin and metalloprotease domain 17 (ADAM17) and other matrix metalloproteinases (MMPs), as a gene ...
2009 NOV 16 ... world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalised healthcare strategy aims at providing medicines and ... Asia Pacific. The CGX arrays are designed by Signature Genomic Laboratories (Signature Genomics) and provide high-resolution, genome-wide analysis of chromosomal abnormalities. ... respective holders. Keywords: , Health, Biotechnology, Clinical Trials, Genetics, Oncology, Internet, Asia, China, Japan, Software, Web Portals, World Wide Web, ...
2009 NOV 23 ... to advance translational research studies in key disease areas such as cancer, diabetesand neurological disorders. Through this collaboration, next generation sequencing ... information to help identify new therapies, diagnostics and preventive strategies. Genomics and biomedical scientists will use three SOLiD™ 3 Plus Systems, next-generation ... significance. Keywords: , Education, University, Health, Biotechnology, Genetics, Research, Science, Agriculture, Agricultural, Agriculture, Conservation, Ecology, ...
